Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002354 · ClinicalTrials.gov registry record · NA
A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients
A NA study, sponsored by Merck Sharp & Dohme.
- Completed
- Registry status
- NA
- Development phase
- 540
- Enrollment target
NCT00002354 is a NA study that has completed, run by Merck Sharp & Dohme. The registered enrollment target is 540 participants.
The verdict
NCT00002354, a NA study, has completed, sponsored by Merck Sharp & Dohme.
- COMPLETED
- Registry status
- NA
- Development phase
- 540 participants
- Enrollment target
Study Summary
The purpose of this study is to see if it is safe and effective to give indinavir sulfate plus stavudine to HIV-infected patients who have already been treated with zidovudine.
Interventions
- DRUG Indinavir sulfate
- DRUG Stavudine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 540 participants |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002354
The ClinicalTrials.gov registry entry for NCT00002354 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 540 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merck Sharp & Dohme, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Indinavir sulfate is the first listed.
NCT00002354 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002354 about?
NCT00002354 is a clinical study titled "A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients". The purpose of this study is to see if it is safe and effective to give indinavir sulfate plus stavudine to HIV-infected patients who have already been treated with zidovudine.
What is the current status of trial NCT00002354?
This trial is currently completed. It is a NA study. The enrollment target is 540 participants.
What interventions are being tested in trial NCT00002354?
The interventions under investigation include: Indinavir sulfate (DRUG), Stavudine (DRUG).
Who is sponsoring clinical trial NCT00002354?
This trial is sponsored by Merck Sharp & Dohme, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.